396
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study

, , , , , & show all
Pages 1363-1373 | Published online: 14 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hillary J Mull, Marlena H Shin, Ryann L Engle, Amy M Linsky, Emily Kalver, Rebecca Lamkin & Jennifer L Sullivan. (2020) Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants. Patient Preference and Adherence 14, pages 1911-1922.
Read now

Articles from other publishers (21)

Takanori Shimizu, Noriyuki Iwama, Hideki Tokunaga, Shun Endo, Shuko Miyahara, Asami Toki, Zen Watanabe, Junko Minato, Chiaki Hashimoto, Masumi Ishibashi, Shogo Shigeta, Muneaki Shimada & Nobuo Yaegashi. (2023) Precautions during Direct Oral Anticoagulant Introduction in Gynecologic Malignancies: A Single-Center Retrospective Cohort Study. Cancers 15:4, pages 1132.
Crossref
Matthew T. Mefford, Hui Zhou, Dongjie Fan, Margaret C. Fang, Priya A. Prasad, Alan S. Go, Cecilia Portugal, John M. Chang & Kristi Reynolds. (2022) Health Literacy and Treatment Satisfaction Among Patients with Venous Thromboembolism. Journal of General Internal Medicine.
Crossref
Lorena Villalba, Marcia Cortés, Cristian Garmendia, Marcos Viruel, Florencia Muñoz, Jorge Suarez & Juan Pablo Costabel. (2022) Health-Related Quality of Life in Patients Under Treatment With Apixaban in Latin America. Current Problems in Cardiology 47:10, pages 101297.
Crossref
Margaret C. Fang, Alan S. Go, Priya A. Prasad, Hui X. Zhou, Anna L. Parks, Dongjie Fan, Cecilia Portugal, Sue Hee Sung & Kristi Reynolds. (2022) Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Thrombosis Research 216, pages 97-102.
Crossref
Nobuhiro Hara, Tetsumin Lee, Toshihiro Nozato, Mao Terui Matsuyama, Shinichiro Okata, Masashi Nagase, Kentaro Mitsui, Giichi Nitta, Keita Watanabe, Ryoichi Miyazaki, Sho Nagamine, Masakazu Kaneko, Tomofumi Nakamura, Yasutoshi Nagata, Takamichi Miyamoto, Toru Obayashi & Takashi Ashikaga. (2022) Effectiveness and Safety of Direct Oral Anticoagulants vs. Warfarin and Recurrence After Discontinuation in Patients With Acute Venous Thromboembolism in the Real World. Circulation Journal 86:6, pages 923-933.
Crossref
Bryan E-Xin Tan, Mohan Rao, Bipul Baibhav, Dmitry Chuprun, Abrar Shah, Deepak L. Bhatt & Jeremiah P. Depta. (2022) Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin Following WATCHMAN in High-Risk Patients. Journal of the Society for Cardiovascular Angiography & Interventions 1:3, pages 100042.
Crossref
Katarzyna Lomper, Maria Łoboz-Rudnicka, Tomasz Bańkowski, Krystyna Łoboz-Grudzień & Joanna Jaroch. (2022) The Influence of Frailty Syndrome and Dementia on the Convenience and Satisfaction with Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation. International Journal of Environmental Research and Public Health 19:9, pages 5355.
Crossref
Thom Kok, Hans de Boer, Bart Witteman, Marcel Hovens, Matthijs van Luin & Houshang Monajemi. (2021) Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric Surgery. Obesity Surgery 32:3, pages 607-614.
Crossref
Francisco J. Guerrero-Márquez, Ignacio Sainz-Hidalgo, Pablo Cristobo Sainz, Inmaculada Sigler Vilches, Alberto Avilés Toscano & Basilio Soto-Espinosa de los Monteros. (2021) Utilidad del cuestionario EQ-5D y CRES-4 para la valoración de la calidad de vida y grado de satisfacción tras el cambio de dicumarínicos por edoxabán: experiencia vida real de un estudio multicéntrico. Medicina Clínica 157:11, pages 530-534.
Crossref
Francisco J. Guerrero-Márquez, Ignacio Sainz-Hidalgo, Pablo Cristobo Sainz, Inmaculada Sigler Vilches, Alberto Avilés Toscano & Basilio Soto-Espinosa de los Monteros. (2021) Effectiveness of the EQ-5D and CRES-4 questionnaire for assessing the impact on the quality of life of patients and the level of satisfaction after exchanging dicumarinics for edoxabán: Real-life experience based on a multicentre study. Medicina Clínica (English Edition) 157:11, pages 530-534.
Crossref
Shahrzad Salmasi, Adenike Adelakun, Abdollah Safari, Leanne Kwan, Jenny MacGillivray, Jason G. Andrade, Marc W. Deyell, Anita Kapanen & Peter Loewen. (2021) Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study. CJC Open 3:11, pages 1347-1356.
Crossref
Kateryna Fedorov, Swati Goel, Margarita Kushnir & Henny H. Billett. (2021) Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists. Research and Practice in Thrombosis and Haemostasis 5:6, pages e12574.
Crossref
Johana Alejandra Moreno-Drada, Alex Junio Silva da Cruz, Matheus Luis Soares de Faria, Luís Otávio Miranda Cota, Maria Auxiliadora Parreiras Martins, Isabela Almeida Pordeus & Mauro Henrique Nogueira Guimarães de Abreu. (2021) Oral Health-Related Quality of Life in Anticoagulated Patients with Warfarin Treatment: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 18:7, pages 3714.
Crossref
Paolo Zappulla & Valeria Calvi. (2021) Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life. TH Open 05:02, pages e200-e210.
Crossref
Kumiko Kirita, Yasuhiro Kodaka, Yoshiaki Shibata, Nobue Ueki, Shuhei Agawa, Hiroshi Yamawaki, Ryota Niikura, Nobutake Yamamichi, Kentaro Izumi, Mariko Hojo, Kyohei Maruyama, Takatsugu Yamamoto, Katya Gudis, Masanori Watanabe, Mitsuru Kaise, Katsuhiko Iwakiri & Seiji Futagami. (2021) Impact of clinical characteristics of colonic diverticular bleeding in extremely elderly patients treated with direct oral anti-coagulant drugs: a retrospective multi-center study. Journal of Clinical Biochemistry and Nutrition 69:2, pages 222-228.
Crossref
Diana-Leh-Ching Ng, Natasya Marliana Bt Abdul Malik, Chee-Shee Chai, Greta-Miranda-Kim-Choo Goh, Seng-Beng Tan, Ping-Chong Bee, Gin-Gin Gan & Asri B. Said. (2020) Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study. Health and Quality of Life Outcomes 18:1.
Crossref
Eva Freisinger, Joachim Gerß, Lena Makowski, Ursula Marschall, Holger Reinecke, Helmut Baumgartner, Jeanette Koeppe & Gerhard-Paul Diller. (2020) Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients. European Heart Journal 41:43, pages 4168-4177.
Crossref
Muhammad Shahid Iqbal, Yaman Walid Kassab, Fahad I. Al-Saikhan, Ziyad S. Almalki, Abdul Haseeb, Muhammad Zahid Iqbal & Majid Ali. (2020) Assessing quality of life using WHOQOL-BREF: A cross-sectional insight among patients on warfarin in Malaysia. Saudi Pharmaceutical Journal 28:8, pages 936-942.
Crossref
Pablo Millares Martin. (2020) Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches. EMJ Hematology, pages 93-99.
Crossref
Rachel Denholm, Howard Thom, William Hollingworth & Rupert Payne. (2020) Uptake of direct oral anticoagulants in primary care: an ecological and economic study. BJGP Open 4:2, pages bjgpopen20X101033.
Crossref
Kahraman COSANSU, Cagın Mustafa UREYEN, Harun KILIC, Bilgehan KARADAG, Aycaturer CABBAR, Huseyin GUNDUZ & Ramazan AKDEMİR. (2020) New Uses of Platelet-Lymphocyte Ratio for Bleeding Risk Stratification in Patients with Nonvalvular Atrial Fibrillation: A Pilot Study. Dicle Tıp Dergisi, pages 24-33.
Crossref